Determining the role of nuclear envelope reformation proteins in regulating the cGAS/STING innate immune response in cancer
确定核膜重组蛋白在调节癌症 cGAS/STING 先天免疫反应中的作用
基本信息
- 批准号:10750669
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AuxinsBiochemicalCRISPR/Cas technologyCancer BiologyCancer cell lineCell LineCellular biologyChromatinChromosomesClupeidaeComplexCyclic GMPCytosolDNADNA BindingDNA Repair PathwayDNA-Binding ProteinsDataData AnalysesDedicationsDefectElectron MicroscopyEndosomesEnzyme-Linked Immunosorbent AssayExposure toFluorescence MicroscopyGene ExpressionGenesGeneticGenomic DNAGenomic InstabilityGoalsHomeImmune signalingImmunofluorescence ImmunologicImmunotherapeutic agentIndividualInnate Immune ResponseInterferonsInterphaseInterventionLearningMalignant NeoplasmsMeasuresMembrane ProteinsMitosisModelingMolecularNuclearNuclear EnvelopeNuclear Inner MembraneOutcomePathway interactionsPhosphorylationProductionProductivityProteinsPublishingRegulationRoleRuptureScientistSignal TransductionSiteSortingSourceStimulator of Interferon GenesSystemTestisTrainingTranscriptTransfectionTumor PromotionWestern BlottingWorkcancer cellcareerchromosome missegregationdesignenv Gene Productsexperimental studyinnate immune pathwaysinsightlight microscopylive cell imagingmicronucleusnovelrecruitresponsesealsensorspatiotemporalsynergismtumortumor growth
项目摘要
PROJECT SUMMARY/ABSTRACT:
In cancer cells, exposure of self DNA to the cytosol is driven by a variety of genomic instabilities such as
micronuclei, chromatin bridges, and nuclear ruptures. This cytosolic DNA can be recognized by cytosolic DNA
sensors such as cGAS (cyclic GMP-AMP synthase), which triggers a downstream innate immune response.
Interestingly and confoundingly, the activation of the cGAS/STING innate immune pathway can protect or
sensitize tumors to immunotherapeutic interventions depending on the specific context. Therefore, insight into
the ways in which cGAS/STING signaling is regulated in cancer can inform targeted intervention. Sources of
cytosolic DNA in cancer cells arise primarily from defects in mitosis that lead to the enclosure of chromosomes
in micronuclei that are prone to rupture. These ruptured micronuclei recruit cGAS and nuclear envelope
reformation (NER) factors—such as LEM2, CHMP7, and BAF—but it remains unknown how, or if, these NER
factors impact cGAS/STING signaling but there is emerging evidence in published and in our preliminary data
that there is potential crosstalk between cGAS/STING signaling and NER proteins. The goal of this proposal
is to provide key insights into the regulation of the innate immune response to cytosolic DNA in cancer
cells by nuclear envelope reformation factors. In order to achieve this goal, I will use transfected herring
testes (HT) DNA and transfected DNA-coated beads as models for cytosolic DNA as this can be more readily
controlled compared to the stochastic formation of micronuclei, only some of which are unstable and prone to
rupture. With this model, I will use CRISPR/Cas9 gene-editing and the auxin-inducible-degron (AID) conditional
degradation system to probe the roles of NER factors in cGAS/STING signaling in response to transfected HT
DNA and DNA beads. This proposal will address fundamental aspects of cell biology and innate immune
signaling that will shed light on immunotherapeutic targets for cancer.
项目概要/摘要:
在癌细胞中,自身 DNA 暴露于细胞质是由多种基因组不稳定性驱动的,例如
微核、染色质桥和核断裂可以被胞质 DNA 识别。
cGAS(环化 GMP-AMP 合酶)等传感器,可触发下游先天免疫反应。
令人困惑的是,cGAS/STING 先天免疫途径的激活可以保护或
根据具体情况使肿瘤对免疫治疗干预敏感。因此,需要深入了解。
cGAS/STING 信号在癌症中的调节方式可以为靶向干预提供信息。
癌细胞中的胞质 DNA 主要源自有丝分裂缺陷,导致染色体封闭
这些破裂的微核会招募 cGAS 和核膜。
重组 (NER) 因子,例如 LEM2、CHMP7 和 BAF,但仍不清楚这些 NER 如何或是否会
影响 cGAS/STING 信号传导的因素,但已发表的数据和我们的初步数据中有新的证据
cGAS/STING 信号和 NER 蛋白之间存在潜在的串扰 该提案的目标。
旨在为癌症中细胞质 DNA 的先天免疫反应的调节提供重要见解
为了实现这一目标,我将使用转染的鲱鱼。
测试 (HT) DNA 和转染的 DNA 包被珠作为胞质 DNA 的模型,因为这更容易
与微核的随机形成相比,微核是受控的,只有其中一些是不稳定的并且容易发生
在这个模型中,我将使用 CRISPR/Cas9 基因编辑和生长素诱导降解决定子 (AID) 条件。
降解系统探测 NER 因子在 cGAS/STING 信号传导中对转染 HT 的反应的作用
DNA 和 DNA 珠子将解决细胞生物学和先天免疫的基本问题。
信号将揭示癌症的免疫治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anthony Wayne Isenhour其他文献
Anthony Wayne Isenhour的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
新骨架紫杉烷二萜baccataxane的化学合成、衍生化和降糖活性研究
- 批准号:82373758
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多源生化数据的药物作用预测并行算法研究
- 批准号:62362004
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
冻融循环介导葡萄糖苷酶与热解碳界面分子机制和生化活性研究
- 批准号:42307391
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型细菌色氨酸羟化酶家族的酶学表征、生化机理与应用研究
- 批准号:32370051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
原位电离在线衍生化和串联质谱高效鉴定糖类同分异构体的分析策略研发
- 批准号:22374079
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Proteomics approaches for illuminating the functions of the dark kinases Nek6, Nek7 & Nek9
阐明暗激酶 Nek6、Nek7 功能的蛋白质组学方法
- 批准号:
10216469 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
RNA Polymerase I Associated Factors: Novel Targets in Cancer Therapy
RNA 聚合酶 I 相关因素:癌症治疗的新靶点
- 批准号:
10327609 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
- 批准号:
10427407 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
- 批准号:
10033704 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别:
Development of novel PIP4K inhibitors to treat p53-null cancer
开发新型 PIP4K 抑制剂来治疗 p53 缺失癌症
- 批准号:
10260471 - 财政年份:2020
- 资助金额:
$ 4.77万 - 项目类别: